TABLE OF CONTENTS
Volume 25, Issue 43 (25 September 2006)
Guest Editor
Top of pageIntroduction
Introduction
A Ashworth and N Rahman
Oncogene 25: 5824; doi:10.1038/sj.onc.1209869
Reviews
Clinical management of BRCA1 and BRCA2 mutation carriers
S M Domchek and B L Weber
Oncogene 25: 5825-5831; doi:10.1038/sj.onc.1209881
Modifiers of risk of hereditary breast cancer
S A Narod
Oncogene 25: 5832-5836; doi:10.1038/sj.onc.1209870
Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations
E Honrado, A Osorio, J Palacios and J Benitez
Oncogene 25: 5837-5845; doi:10.1038/sj.onc.1209875
Basal-like breast cancer and the BRCA1 phenotype
N C Turner and J S Reis-Filho
Oncogene 25: 5846-5853; doi:10.1038/sj.onc.1209876
The role of BRCA1 in transcriptional regulation and cell cycle control
P B Mullan, J E Quinn and D P Harkin
Oncogene 25: 5854-5863; doi:10.1038/sj.onc.1209872
The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability
K Gudmundsdottir and A Ashworth
Oncogene 25: 5864-5874; doi:10.1038/sj.onc.1209874
Fanconi anaemia genes and susceptibility to cancer
C G Mathew
Oncogene 25: 5875-5884; doi:10.1038/sj.onc.1209878
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
B Evers and J Jonkers
Oncogene 25: 5885-5897; doi:10.1038/sj.onc.1209871
Models of genetic susceptibility to breast cancer
A C Antoniou and D F Easton
Oncogene 25: 5898-5905; doi:10.1038/sj.onc.1209879
ATM and breast cancer susceptibility
M Ahmed and N Rahman
Oncogene 25: 5906-5911; doi:10.1038/sj.onc.1209873
